Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

11.48
+0.20001.77%
Post-market: 11.33-0.1500-1.31%19:30 EDT
Volume:664.45K
Turnover:7.48M
Market Cap:222.04M
PE:-1.89
High:11.56
Open:11.27
Low:10.60
Close:11.28
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.24
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:2.17
PE(LYR):-1.95

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 20

Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers

Dow Jones
·
May 19

Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 15

Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates

TIPRANKS
·
May 14

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

THOMSON REUTERS
·
May 14

Corbus Pharmaceuticals Price Target Maintained With a $45.00/Share by Guggenheim

Dow Jones
·
May 13

Oppenheimer Adjusts Price Target on Corbus Pharmaceuticals to $54 From $57, Maintains Outperform Rating

MT Newswires Live
·
May 13

Wedbush Remains a Buy on Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 13

Corbus Pharma CEO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies

TIPRANKS
·
May 13

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 13

Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)

TIPRANKS
·
May 13

Corbus Pharmaceuticals Q1 EPS $(1.23) Misses $(1.22) Estimate

Benzinga Earnings
·
May 12

Corbus Q1 FY26 net loss widens to $23 million; operating expenses rise to $24.3 million

Reuters
·
May 12

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
May 12

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

Corbus hosts ASCO KOL event on updated CRB-701 HNSCC Phase 1/2 data

Reuters
·
May 05